# ARS Pharmaceuticals, Inc.: Form 8-K, filed Mar 13, 2023

- Company: [ARS Pharmaceuticals, Inc.](/companies/spry.md) (CIK 1671858)
- Form: 8-K
- Filed: 2023-03-13
- Accepted by EDGAR: Mar 13, 2023, 09:26 ET
- Period: 2023-03-13
- Accession: 0001193125-23-068584
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1671858/000119312523068584/d444956d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1671858/000119312523068584/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1671858/000119312523068584/d444956d8k.htm

Filed Mar 13, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-068584. Last ingested by Listed: Nov 10, 2026, 04:18 ET. No prices; not investment advice.
